Cargando…

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients

Detalles Bibliográficos
Autores principales:	Tecza, Karolina, Pamula-Pilat, Jolanta, Lanuszewska, Joanna, Grzybowska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674903/ http://dx.doi.org/10.1186/1897-4287-13-S2-A10

Ejemplares similares

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2016)

Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms, efficiency and toxicity of cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
por: Budryk, M, et al.
Publicado: (2012)

Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
por: Pamuła-Piłat, Jolanta, et al.
Publicado: (2020)

High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
por: Wagner, Kerstin, et al.
Publicado: (2007)

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age
por: Huszno, Joanna, et al.
Publicado: (2020)

Insights from pharmacogenetic studies of antidepressants
por: Mandelli, Laura
Publicado: (2010)

Jeffrey L. Ponsky, MD, FACS
Publicado: (2019)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015
por: Thompson, Ella R., et al.
Publicado: (2017)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
por: Krajewska, Jolanta, et al.
Publicado: (2013)

Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland
por: Pamuła, Jolanta, et al.
Publicado: (2006)

Novel approaches such as pharmacogenetics and liquid biopsies in tumor treatment in the era of personalized therapy
por: Kralickova, Milena, et al.
Publicado: (2014)

A Festschrift in Honor of Edward M. Messing, MD, FACS
por: Joseph, Jean V., et al.
Publicado: (2018)

High-dose chemotherapy in breast cancer: Dutch randomized studies
por: Rodenhuis, S, et al.
Publicado: (2001)

Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014)

Side effect management
por: Pellis, Tommaso
Publicado: (2015)

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy
por: Del Re, Marzia, et al.
Publicado: (2014)

Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Yulian, Erwin Danil, et al.
Publicado: (2021)

Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011)

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging
por: Turnbull, LW, et al.
Publicado: (2002)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach
por: Jäger, CM, et al.
Publicado: (2001)

Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
por: Dudaladava, Volha, et al.
Publicado: (2006)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
por: Cedeño, Heidy, et al.
Publicado: (2007)

Side effects of the leukotriene receptor antagonists in asthmatic children
por: Can, Demet, et al.
Publicado: (2015)

Hormone replacement therapy (HRT): indications and side effects
por: Whitehead, MI
Publicado: (2002)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01
por: Nitz, U, et al.
Publicado: (2001)

Cost-Effectiveness Analysis of Two Chemotherapy Regiments FAC vs. Taxane for Operable Breast Cancer Patients in Indonesia
por: Saptaningsih, Agusdini Banun, et al.
Publicado: (2022)

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?
por: Kecskeméti, Valéria, et al.
Publicado: (2011)

On-site audits of the two clinical trials reported from South Africa involving high-dose chemotherapy (HDC) therapy for breast cancer
por: Weiss, RB, et al.
Publicado: (2001)

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors
por: Huszno, Joanna, et al.
Publicado: (2022)

PC-FACS
por: Arnold, Robert M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qfc3ubmap7fp2r8ej47cafj10c